Skip to main content

JM sells Battery Materials

26th May 2022

Submitted by:

Andrew Warmington

Johnson Matthey (JM) has exited from the batteries market by selling most of its Battery Materials business to EV Metals Group for £50 million and the Canadian part to Nano One Materials for C$10.25 million. Both buyers are specialists in the field.

EV Metals is taking the battery technology centres at Oxford and Billingham, UK, and Moosburg, Germany; a pilot plant and laboratories also at Billingham; a cathode active materials (CAMs) plant under construction in Konin, Poland (pictured); JM’s eLNO technology; and associated patents, licences and other IP rights.

The company is thus adding downstream production of CAMs for electric vehicle (EV) and battery cell manufacturers to its upstream mining and chemical processing activities. About 100 people are transferring from JM, which is also taking a minority equity stake in EVM and a seat on the board. The deal should be completed in the summer.

The sale of JM Battery Materials Canada brings NanoOne R&D, pilot-scale, commercial-scale cathode production and product qualification and QA systems, qualified for Tier 1 automotive lithium-ion cell manufacturers plus a 2,400 tonnes/year lithium iron phosphate facility in Candiac, Québec. This deal is expected to be completed by the end of 2022.

Separately but also in line with its strategy after exiting form batteries, JM is investing €20 million in Enapter as part of an ongoing partnership. Enapter specialises in AEM electrolysis technology, which aims to drive the cost drive down the cost of green hydrogen to be competitive with fossil fuels. The two will collaborate on the development of advanced components for Enapter’s AEM stacks using catalysts from JM. They will also investigate opportunities for the recycling of production scraps and components from end-of-life products.

In another ongoing part of the company’s transformation, Johnson Matthey Health has announced that its new name under the ownership of Altaris Capital Partners will be Veranova. The name is derived from Latin words meaning ‘true’ and ‘new’. Veranova is a CDMO focused on APIs, with about 900 employees and operations in the US, the UK and China.

UPL to split out specialities

Indian agrochemicals giant UPL has announced plans to transfer its speciality chemicals business, including agrochemical

Submitted by:

Andrew Warmington

AI for SAPs

Together with Algo Artis, Japan’s Nippon Shokubai has developed an algorithm-based means for the production

Submitted by:

Andrew Warmington

Nippon Shokubai's API Facility in Japan

Nucleic acid API boost

Nippon Shokubai is to expand its GMP capacity for nucleic APIs tenfold It will install

Submitted by:

Andrew Warmington

Flamma's facility in Dalian

Flamma opens in China

Italian CDMO Flamma Group has officially opened its new cGMP plant at Dalian, China, where

Submitted by:

Andrew Warmington

GL Chemtec has opened a new kilo lab

GL Chemtec completes kilo lab

CDMO GL Chemtec has announced the completion of a cGMP kilo lab at Oakville, Ontario

Submitted by:

Andrew Warmington

Sterling's facility at Deeside, UK

CDMOs in ADC investments

Five CDMOs across the world have separately announced investments in antibody-drug conjugates (ADCs). Piramal Pharma is

Submitted by:

Andrew Warmington

Halozyme has dropped its approach to buy Evotec

Halozyme abandons Evotec bid

San Diego-based biopharmaceutical company Halozyme Therapeutics has withdrawn the offer it made for Evotec after

Submitted by:

Andrew Warmington

Afyren Neoxy plant

Milestones for two greentech firms

Afyren has achieved continuous production at its Afyren Neoxy plant at Clermont-Ferrand (pictured)

Submitted by:

Andrew Warmington

Origin by Ocean derives its materials from sargassum

CABB in algae biorefinery deal

CABB has agreed a strategic partnership to establish a first-in-kind algae biorefinery at its site at Kokkola

Submitted by:

Andrew Warmington

First waste-based biosurfactants

Belgian start-up AmphiStar has launched what it claims are the first fully upcycled biobased surfactants

Submitted by:

Andrew Warmington

Aether to supply Seqens

Indian firm Aether Industries has entered into a manufacturing agreement with Chemoxy International, a UK-based

Submitted by:

Andrew Warmington

New model for biocatalysts

BASF, the Austrian Research Centre of Industrial Biotechnology (ACIB) and the University of Graz in

Submitted by:

Andrew Warmington

CBE JU funds 31 more projects

The Circular Bio-based Europe Joint Undertaking (CBE JU), a €2 billion partnership between the EU

Submitted by:

Andrew Warmington

Ribbon cutting ceremony at Lubrizol's new office

Lubrizol opens London office

Lubrizol has opened a new office in Hammersmith, London. This will be home to a

Submitted by:

Andrew Warmington

Sudarshan to buy Heubach

India’s Sudarshan Chemical Industries (SCIL) has entered into a definitive agreement to acquire the Heubach

Submitted by:

Andrew Warmington

Alliance in natural fragrances

Sensegen, a US-based specialist in biotech-enabled fragrances, notably a new class of natural musk raw

Submitted by:

Andrew Warmington

Croda breaks ground in China

Croda International has broken ground for a low-carbon, multi-purpose production facility on a greenfield site

Submitted by:

Andrew Warmington

CCT collaboration for Givaudan

Flavours and fragrances giant Givaudan has agreed a research collaboration for the development of sustainable

Submitted by:

Andrew Warmington

REACH Authorisation

Candidate List ‘reaches’ 250

The European Chemicals Agency (ECHA) has added three more substances to the Candidate List of

Submitted by:

Andrew Warmington

Staff at Brenntag's newly acquired Czech site

CO2-free distribution site first

Brenntag has officially inaugurated what it claims to be the first CO2-emission-free chemical distribution site

Submitted by:

Andrew Warmington